AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (2.9 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Rapid Communication | Open Access

Ammonia-induced cell death patterns in glioblastoma: Immune landscape, prognostic signature, and therapeutic target identification

Sheng-Qi Hua,b,c,fJing Wangb,c,fJing Wangd,fChun Zengc,e( )Rudong Chena( )
Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China
Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China
Department of Neurosurgery, Beijing TianTan Hospital, Capital Medical University, Beijing 100070, China
Department of Neurosurgery, Peking University International Hospital, Beijing 100070, China
China National Clinical Research Center for Neurological Diseases, Beijing 100070, China

f These authors contribute equally to this work.

Peer review under the responsibility of Chongqing Medical University.

Show Author Information

References

【1】
【1】
 
 
Genes & Diseases

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Hu S-Q, Wang J, Wang J, et al. Ammonia-induced cell death patterns in glioblastoma: Immune landscape, prognostic signature, and therapeutic target identification. Genes & Diseases, 2026, 13(5). https://doi.org/10.1016/j.gendis.2025.101979

7

Views

0

Downloads

0

Crossref

0

Web of Science

0

Scopus

0

CSCD

Received: 22 June 2025
Published: 12 December 2025
© 2025 The Authors.

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).